Medicalization and pharmaceuticalization at the intersections: Looking backward, sideways and forward

Social Science and Medicine

Volumn 75, Issue 5, 2012, Pages 775-783

  Bell, Susan E ^a   Figert, Anne E ^b  

^a BOWDOIN COLLEGE   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Biomedicalization; Direct to consumer advertising; Medicalization; Pharmaceuticalization; Pharmaceuticalization of public health; Pharmaceuticals; Postmodern theory

Indexed keywords

CONCEPTUAL FRAMEWORK; DRUG; MEDICINE; MODERNIZATION; PUBLIC HEALTH;

CONCEPTUAL FRAMEWORK; CONSUMER ATTITUDE; DEVELOPING COUNTRY; DRUG COST; DRUG INDUSTRY; DRUG LEGISLATION; DRUG MARKETING; DRUG RESEARCH; DRUG SAFETY; DRUG SEEKING BEHAVIOR; FOOD AND DRUG ADMINISTRATION; HEALTH CARE AVAILABILITY; HEALTH CARE CONCEPTS; HEALTH CARE DELIVERY; HEALTH CARE DISTRIBUTION; HUMAN; MASS MEDIUM; MEDICAL LITERATURE; MEDICAL PRACTICE; MEDICALIZATION; OFF LABEL DRUG USE; PHARMACEUTICALIZATION; POLITICAL SYSTEM; POPULATION DYNAMICS; PRESCRIPTION; REVIEW; SOCIAL CLASS; SOCIAL CONTROL; SOCIAL PROBLEM;

DRUG THERAPY; FORECASTING; HUMANS; POSTMODERNISM; TERMINOLOGY AS TOPIC; WORLD HEALTH;

EID: 84862758615     PISSN: 02779536     EISSN: 18735347     Source Type: Journal    
DOI: 10.1016/j.socscimed.2012.04.002     Document Type: Review

References (104)

1. Abraham J. Building on sociological understandings of the pharmaceutical industry or reinventing the wheel? Response to Joan Busfield's 'Pills, Power, People'. Sociology 2007, 41(4):727-736.
2. Abraham J. The sociological concomitants of the pharmaceutical industry and medications. Handbook of medical sociology 2010, 290-308. Vanderbilt University Press, Nashville. C. Bird, P. Conrad, A.M. Fremont, S. Timmermans (Eds.).
3. Abraham J. Pharmaceuticalization of society in context: theoretical, empirical and health dimensions. Sociology 2010, 44(4):603-622.
4. Abraham J. Evolving sociological analyses of 'Pharmaceuticalisation': a response to Williams, Martin and Gabe. Sociology of Health & Illness 2011, 33:726-728.
5. Alway J. The trouble with gender: tales of the still-missing feminist Revolution in sociological theory. Sociological Theory 1995, 13:209-228.
6. Ballard K., Elston M.A. Medicalisation: a multi-dimensional concept. Social Theory & Health 2005, 3:228-241.
7. Barker K. The fibromyalgia story: Medical authority and women's worlds of pain 2005, Temple University Press, Philadelphia.
8. Barker K.K. The social construction of illness: medicalization and Contested illness. Handbook of medical sociology 2010, 147-162. Vanderbilt University Press, Nashville. C. Bird, P. Conrad, A.M. Fremont, S. Timmermans (Eds.).
9. Bell S.E. Changing ideas: the medicalization of menopause. Social Science & Medicine 1987, 24(6):535-542.
10. Bell S.E. Premenstrual syndrome and the medicalization of menopause: a sociological perspective. The premenstrual syndrome: Ethical and legal implications in a biomedical perspective 1987, 151-173. Plenum, New York. B. Ginsburg, B. Frank Carter (Eds.).
11. Bell S.E., Figert A. Gender and the medicalization of health care. Palgrave handbook of gender and healthcare 2010, 107-122. Palgrave Macmillan. E. Kuhlmann, E. Annandale (Eds.).
12. Biehl J. The activist state: global pharmaceuticals, AIDS, and citizenship in Brazil. Social Text 2004, 22(3):105-132.
13. Biehl J. Pharmaceutical governance. Global pharmaceuticals: Ethics, markets, practices 2006, 206-239. Duke University Press, Durham. A. Petryna, A. Lakoff, A. Kleinman (Eds.).
14. Biehl J. Drugs for all: the future of global AIDS treatment. Medical Anthropology 2008, 27(2):99-105.
15. Handbook of medical sociology 2000, Prentice Hall, Upper Saddle River. C. Bird, P. Conrad, A. Fremont (Eds.).
16. Boston Women's Health Book Collective Our bodies, ourselves: A book by and for women 1973, Simon & Schuster, New York.
17. Brandt A. Introduction. Medicalization: A medical humanities symposium 2009, The Humanities Center, Harvard University, Cambridge, MA.
18. Social movements in health 2005, Blackwell Publishing, Oxford, UK. P. Brown, S. Zavestoski (Eds.).
19. Burawoy M. Introduction: reaching for the global. Global ethnography: Forces, connections, and imaginations in a postmodern world 2000, 1-40. University of California Press, Berkeley. M. Burawoy, J. A.Blum, S. George, Z. Gille, T. Gowan, L. Haney, M. Klawiter, S.H. Lopez, S.O. Riain, M. Thayer (Eds.).
20. Busfield J. Pills, power, people: sociological understandings of the pharmaceutical industry. Sociology 2006, 40(2):297-314.
21. Busfield J. Sociological understandings of the pharmaceutical industry: a response to John Abraham. Sociology 2007, 41(4):737-739.
22. Busfield J. 'A Pill for Every Ill': explaining the expansion in medicine use. Social Science & Medicine 2010, 70(6):934-941.
23. Cataldo F. New forms of citizenship and socio-political inclusion: accessing antiretroviral therapy in a Rio de Janeiro favela. Sociology of Health & Illness 2008, 30:900-912.
24. Clarke A.E., Mamo L., Fishman J.R., Shim J.K., Fosket J.R. Biomedicalization: technoscientific transformations of health, illness, and U.S. Biomedicine. American Sociological Review 2003, 68:161-194.
25. Clarke A.E., Shim J.K. Medicalization and biomedicalization Revisited: technoscience and transformations of health, illness and biomedicine. Salute e Societa: The medicalization of life 2009, 209-241. FrancoAngeli. A. Maturo, P. Conrad (Eds.).
26. Biomedicalization: Technoscience health and illness in the U.S. 2010, Duke University Press. A. Clarke, J. Shim, L. Mamo, J.R. Fosket, J.R. Fishman (Eds.).
27. Conrad P. The discovery of hyperkinesis: notes on the medicalization of deviant behavior. Social Problems 1975, 23:12-21.
28. Conrad P. Medicalization and social control. Annual Review of Sociology 1992, 18:209-232.
29. Conrad P. The shifting engines of medicalization. Journal of Health and Social Behavior 2005, 46:3-14.
30. Conrad P. The medicalization of society: On the transformation of human conditions into treatable disorders 2007, Johns Hopkins University Press, Baltimore.
31. Conrad P., Mackie T., Mehrotra A. Estimating the costs of medicalization. Social Science & Medicine 2010, 70:1943-1947.
32. Conrad P., Schneider J. Deviance and medicalization: from badness to sickness 1980, Mosby, St. Louis.
33. Crossley N. Contesting psychiatry: Social movements in mental health 2006, Routledge, London, UK.
34. Ebeling M. " Get with the Program!" : pharmaceutical marketing, symptom checklists, and self-diagnosis. Social Science & Medicine 2011, 73:825-832.
35. Figert A. Women and the ownership of PMS 1996, Aldine de Gruyter, Hawthorne.
36. Figert A. The consumer turn in medicalization: future Directions with historical foundations. The handbook of the sociology of health, illness & healing: Blueprint for the 21st century 2011, 291-307. Springer, New York. B. Pescosolido, J. Martin, J. Mcleod, A. Rogers (Eds.).
37. Foucault M. Birth of the clinic 1963, Pantheon, New York City.
38. Foucault M. The history of sexuality 1978, Pantheon Books, New York.
39. Fox N.J., Ward K.J. Pharma in the bedroom. and the kitchen. The pharmaceuticalisation of daily life. Sociology of Health & Illness 2008, 30(6):856-868.
40. Freidson E. Profession of medicine: A study of the sociology of applied knowledge 1970, Dodd, Mead and Company, Inc, New York.
41. Furedi F., et al. Symposium: the American way of medicalization. Society 2006, 43(6):14-56.
42. Giddens A. Social theory and modern sociology 1987, Stanford University Press.
43. Halpern S. Medicalization as professional process: postwar trends in pediatrics. Journal of Health and Social Behavior 1990, 31(1):28-42.
44. Haraway D.J. A Cyborg Manifesto: science, technology, and socialist-feminism in the late twentieth century. Simians, cyborgs, and women: The reinvention of nature 1991, 149-181. Routledge, New York City. D.J. Haraway (Ed.).
45. Illich I. Medical nemesis 1976, Pantheon, New York.
46. IMS Institute for Healthcare Informatics IMS forecasts global pharmaceutical market growth of 5-8% annually through 2014; maintains expectations of 4-6% growth in 2010 2010, IMS Institute for Healthcare Informatics, Parsippany, NJ, Accessed 22.03.12. http://www.imshealth.com/portal/site/ims/menuitem.d248e29c86589c9c30e81c033208c22a/?vgnextoid=4b8c410b6c718210VgnVCM100000ed152ca2RCRD&vgnextfmt=default.
47. IMS Institute for Healthcare Informatics The global use of medicines: outlook through 2015. IMS Institute reports 2011, 28. IMS Institute for Healthcare Informatics, Parsippany, NJ, Accessed 22.03.12. http://www.imshealth.com/portal/site/ims/, I.M.S. Informatics (Ed.).
48. Kahn J. Surrogate markers and surrogate marketing in biomedicine: the regulatory etiology and commercial progression of 'Ethnic' drug development. Biomedicalization: Technoscience, health and illness in the U.S 2010, 263-288. Duke University Press, Durham, NC. A. Clarke, J. Shim, L. Mamo, J.R. Fosket, J.R. Fishman (Eds.).
49. Kleinman A. Medical anthropology and mental health: five questions for the next fifty years. Medical anthropology at the intersections 2012 forthcoming, 178-196. Duke University Press. M.C. Inhorn (Ed.).
50. Kuhlmann E. From women's health to gender mainstreaming and back again: linking feminist agendas and new governance in healthcare. Current Sociology 2009, 57:135.
51. Laing R.D. The divided self 1960, Tavistock, London.
52. Laing R.D. The self and others 1961, Tavistock, London.
53. Levitt P., Jaworsky B.N. Transnational migration studies: past developments and future trends. Annual Review of Sociology 2007, 33:129-156.
54. The risks of prescription drugs 2010, Columbia University Press, New York. D.W. Light (Ed.).
55. Light D.W. Health-Care professions, markets, and countervailing powers. Handbook of medical sociology 2010, 270-289. Vanderbilt University Press, Nashville, TN. C.E. Bird, P. Conrad, A.M. Fremont, S. Timmermans (Eds.).
56. Lippman A. Prenatal genetic testing and screening: constructing needs and reinforcing inequities. American Journal of Law & Medicine 1991, 17(1 & 2):15-50.
57. Lock M.M. Twice dead: Organ transplants and the reinvention of death 2002, University of California Press, Berkeley.
58. Lock M.M. Medicalization and the naturalization of social control. Encyclopedia of medical anthropology; health and illness in the world's cultures 2004, 116-124. Kluwer Academic/Plenum Publishers, New York. C.W. Ember, M. Ember (Eds.).
59. Loe M. The rise of viagra 2004, New York University Press, New York.
60. Lupton D. Foucault and the medicalisation critique. Foucault, health and medicine 1997, 94-110. Routledge, London and New York. A. Peterson, R. Bunton (Eds.).
61. McCrea F. The politics of menopause: the 'Discovery' of a deficiency disease. Social Problems 1983, 31:111-123.
62. Mamo L. Queering reproduction: Achieving pregnancy in the age of technoscience 2007, Duke University Press, Durham.
63. Salute e Societa: The medicalization of life 2009, FrancoAngeli. A. Maturo, P. Conrad (Eds.).
64. Metzl J.M., Herzig R.M. Medicalisation in the 21st century: introduction. Lancet 2007, 369:697-698.
65. Moore K., Kleinman D.L., Hess D., Frickel S. Science and neoliberal globalization: a political sociological approach. Theory and Society 2011, 40:505-532.
66. Moynihan R., Heath I., Henry D. Selling sickness: the pharmaceutical industry and disease mongering. British Medical Journal 2002, 234:886-890.
67. Moynihan R., Henry D. The fight against disease mongering: generating knowledge for action. PLoS Medicine 2006, 3(4):425-428.
68. Nguyen V.-K. Antiretroviral globalism, biopolitics, and therapeutic citizenship. Global Assemblages 2005, 124-144. Blackwell Publishing, Malden. A. O. a. S. J. Collier (Ed.).
69. Nichter M. Pharmaceuticals, the commodification of health, and the health care-medicine use transition. Anthropology and international health: Asian case studies 1996 [1989], 265-326. Gordon and Breach Publishers, Amsterdam. M. Nichter, M. Nichter (Eds.).
70. Nye R. The evolution of the concept of medicalization in the twentieth century. Journal of the History of the Behavioral Sciences 2003, 39(2):115-129.
71. Padamsee T.J. The pharmaceutical corporation and the " Good Work" of managing women's bodies. Social Science & Medicine 2011, 72(8):1342-1350.
72. Payer L. Disease-mongers: how doctors, drug companies, and insurers are making You Feel Sick 1992, J. Wiley, New York.
73. Payton A.R., Thoits P.A. Medicalization, direct-to-consumer advertising, and mental illness stigma. Society and Mental Health 2011, 1(1):55-70.
74. Pescosolido B.A., Mcleod J., Alegria M. Confronting the second social contract: the place of medical sociology in research and policy for the twenty-first century. Handbook of medical sociology 2000, 411-426. Prentice Hall, Upper Saddle River. C. Bird, P. Conrad, A. Fremont (Eds.).
75. Pescosolido B.A., Martin J.K., Long J.S., Medina T.R., Phelan J.C., Link B.G. " A Disease Like any Other?" A decade of change in public reactions to schizophrenia, depression, and alcohol dependence. American Journal of Psychiatry 2010, 167(11):1321-1330.
76. Petryna A. Globalizing human subjects research. Global pharmaceuticals: Ethics, markets, practices 2006, 33-60. Duke University Press, Durham, NC. A. Petryna, A. Lakoff, A. Kleinman (Eds.).
77. Global Pharmaceuticals: Ethics, markets, practices 2006, University of California, Berkeley. A. Petryna, A. Lakoff, A. Kleinman (Eds.).
78. Pitts J.R. Social control. International encyclopedia of the social sciences 1968, Macmillan, New York City, 381-397.
79. Pollock A. Transforming the critique of big pharma. BioSocieties 2011, 6:106-118.
80. Pratt L., Brody D., Gu Q. Antidepressant use in persons aged 12 and over: United States, 2005-2008. NCHS data brief, no. 76 2011, National Center for Health Statistics, Hyattsville, MD. N.C.H. Statistics (Ed.).
81. Riessman C.K. Women and medicalization: a new perspective. Social Policy 1983, 3-18.
82. Riska E. Gendering the medicalization thesis. Advanced in Gender Research 2003, 7:59-87.
83. Rose N. Beyond medicalisation. Lancet 2007, 369:700-702.
84. Rose N., Novas C. Biological citizenship. Global assemblages: Technology, politics, and ethics as anthropological problems 2005, 439-463. Blackwell. A. Ong, S.J. Collier (Eds.).
85. Rosenberg C. Contested boundaries: psychiatry, disease and diagnosis. Perspectives in Biology and Medicine 2006, 49(3):407-424.
86. Medicalized masculinities 2006, Temple University Press, Philadelphia. D. Rosenfeld, C. Faircloth (Eds.).
87. Scott W. PTSD in the DSM-III: a case in the politics of diagnosis and disease. Social Problems 1990, 37(3):294-310.
88. Shim J.K. The stratified biomedicalization of heart disease: expert and lay perspectives and racial and class inequality. Biomedicalization: Technoscience health and illness in the U.S 2010, 218-241. Duke University Press, Durham, NC. A. Clarke, J. Shim, L. Mamo, J.R. Fosket, J.R. Fishman (Eds.).
89. Shostak S., Conrad P., Horwitz A.V. Sequencing and its consequences: path dependence and the relationships between genetics and medicalization. American Journal of Sociology 2008, 114:S287-S316.
90. Strong P. Sociological imperialism and the profession of medicine: a critical examination of the thesis of medical imperialism. Social Science & Medicine 1979, 13A:199-215.
91. Strong P. The academic encirclement of medicine. Sociology of Health & Illness 1984, 6:339-358.
92. Szasz T. The myth of mental Illness: Foundations of a theory of personal conduct 1961, HarperCollins, New York.
93. Victora C.G., Barreto M.L., Leal M.d.C., Monteiro C.A., Schmidt M.I., Bastos P., et al. Health conditions and health-policy innovations in Brazil: the way forward. The Lancet 2011, 377:2042-2053.
94. Waitzkin H. Latent function of the sick role in various institutional settings. Social Science & Medicine 1971, 5:45-75.
95. Waitzkin H., Waterman B. The exploitation of illness in capitalist society 1974, Bobbs-Merrill, Indianapolis, IN.
96. Whitmarsh I. Biomedical ambivalence: asthma diagnosis, the pharmaceutical, and other contradictions in Barbados. American Ethnologist 2008, 35:49-63.
97. Whitmarsh I. Biomedical ambiguity: Race, asthma, and the contested meaning of genetic research in the Caribbean 2008, Cornell University Press, Ithaca and London.
98. Williams S.J. Sociological imperialism and the profession of medicine revisited: where are we now?. Sociology of Health & Illness 2001, 23:135-158.
99. Williams S.J., Gabe J., Davis P. The sociology of pharmaceuticals: progress and Prospects. Sociology of Health & Illness 2008, 30(6):813-824.
100. Williams S.J., Martin P., Gabe J. The pharmaceuticalization of society? A framework for analysis. Sociology of Health & Illness 2011, 33:710-725.
101. Williams S.J., Martin P., Gabe J. Evolving sociological analyses of 'Pharmaceuticalisation': a Reply to Abraham. Sociology of Health & Illness 2011, 33:729-730.
102. Williams S.J., Seale C., Boden S., Lowe P., Steinberg D.L. Waking up to sleepiness: modafinil, the media and the pharmaceuticalisation of everyday/night life. Sociology of Health & Illness 2008, 30:839-855.
103. Zacher M.W., Keefe T.J. The politics of global health governance: United by contagion 2008, Palgrave MacMillan, New York.
104. Zola I. Medicine as an institution of social control. Sociological Review 1972, 20:487-504.